Olivier et al. demonstrated that the combination of CA-125 with transvaginal ultrasound (TVUS) yielded a positive predictive value of 40% for ovarian cancer; however, this approach proved more effective for detecting advanced-stage disease [17]. This evidence concerns the gene MUC16 and ovarian carcinoma.